SCHEMBL574547

SCHEMBL574547

OC1CC=COC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1821763 0.74
SCHEMBL12902107 0.67
SCHEMBL17461287 0.67
SCHEMBL15243722 0.67
SCHEMBL1821273 0.65
SCHEMBL17942996 0.64 TSHR (0.31)
SCHEMBL191970 0.64
SCHEMBL9084173 0.64
SCHEMBL27580506 0.63
SCHEMBL414311 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107405337-A Substituted chroman and application method 艾伯维公司 2017-11-28 CN disclosed
EP-1891076-B1 SUBSTITUTED TETRAHYDROQUINOLINES MERCK PATENT GMBH (DE) 2016-01-27 EP disclosed
US-7893082-B2 Antitumor agents; anticancer agents MERCK PATENT GMBH (DE) 2011-02-22 US disclosed
US-7893082-B2 Antitumor agents; anticancer agents MERCK PATENT GMBH (DE) 2011-02-22 US disclosed
EP-1996579-A2 ANTIBIOTIC COMPOUNDS Actelion Pharmaceuticals Ltd. (CH) 2008-12-03 EP disclosed
US-20080194615-A1 Antitumor agents; anticancer agents MERCK PATENT GMBH (DE) 2008-08-14 US disclosed
US-20080194615-A1 Antitumor agents; anticancer agents MERCK PATENT GMBH (DE) 2008-08-14 US disclosed
WO-2007105154-A2 ANTIBIOTIC COMPOUNDS ACTELION PHARMACEUTICALS LTD (CH) 2007-09-20 WO disclosed
WO-2007054138-A1 SUBSTITUTED TETRAHYDROQUINOLINES MERCK PATENT GMBH (DE) 2007-05-18 WO disclosed